PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: innovation
Fixing Innovation: Lilly's CEO Says Why, and How
Following his keynote address last week at the Financial Times US Healthcare and Life Sciences Conference in New York, Eli Lilly CEO John Lechleiter huddled into a corridor to speak with PharmExec about his agenda as incoming chairman of PhRMA, and how to fix innovation.
Posted in Europe, Events, FDA, Global, IP, Legal, Market Access, Meetings, People, R&D, Regulatory, Safety, Strategy, Technology, healthcare, leadership, pricing Also tagged CEO, CEOs, drug safety, Eli Lilly, Financial Times, Global, healthcare reform, IP, IPAB, Lilly, PhRMA, policy, R&D 1 Comment
Clayton Christensen on the Future of Pharma
A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
Posted in Biotech, Events, FDA, IP, People, R&D, Regulatory, Safety, Technology, Uncategorized, healthcare, leadership Also tagged business model, change, Clayton Christensen, commercial model, conference, FDA, health analytics, Mitt Romney, Politics, public policy, SaS, Strategy 1 Comment
Close to Home: Is Good Health Communicable?
The 2011 Edelman Health Barometer suggests that—in the same way that we spread colds, diseases, and other illnesses from person to person—good health and healthy behaviors can also be spread. Can pharma play a pivotal role in the good-health epidemic?
Energy. An active lifestyle. Mental and emotional stability. Absence of disease. Nutrition. These are some of [...]
Posted in Technology, healthcare, social media Also tagged Health, online, pharma. business 1 Comment
Patient Privacy Fears Taint UK Innovation Plans
Patient Privacy Fears Taint UK Innovation Plans
The Conservative arm of the UK’s coalition government flexed its private-sector-friendly muscles again on Monday with the announcement that the National Health Service should be ‘opened up’ to private healthcare firms. In a pharma-friendly speech peppered with the usual buzzwords, Prime Minister David Cameron said: “The end-game is for [...]
BIO 2012: The Case for Collaboration